ALBA BIOSCIENCE LIMITED

AliveDx is a Swiss-based in-vitro diagnostics company with over 30 years of experience specializing in innovative solutions for autoimmune diseases, allergies, immunohematology, and disease screening. Operating from headquarters in Eysins, Switzerland, with significant facilities in the UK (Scotland) and offices across the US, UAE, and other regions, AliveDx employs approximately 500 personnel. The company has transitioned from public to private ownership while maintaining its commitment to advancing clinical diagnostics globally. AliveDx offers three primary product lines: MosaiQ®, a fully automated microarray platform enabling simultaneous complex multiplex testing with fast time-to-diagnosis; LumiQ®, an all-in-one immunofluorescence (IFA) automation solution providing turnkey workflow integration; and Alba, a comprehensive manual blood typing and immunohematology reagent portfolio. These solutions are designed to optimize laboratory workflows, enhance productivity, and deliver clinical and economic value in diagnostic settings. The company has achieved multiple regulatory milestones and maintains Great Place to Work certification, underscoring its commitment to innovation and organizational excellence in clinical diagnostics.